Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

34results about How to "Medication safety" patented technology

Traditional Chinese medicine compound composition with treatment effect on rapid atrial fibrillation and preparation method of traditional Chinese medicine compound composition

The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine compound composition with a treatment effect on rapid atrial fibrillation and a preparation method of the traditional Chinese medicine compound composition. The traditional Chinese medicine composition comprises radix pseudostellariae, rhizoma polygonati, radix rehmanniae preparata, radix paeoniae alba, spina date seed, mulberry, jujube kernel, schisandra chinensis, Huai wheat, radix ophiopogonis, ligusticum wallichii, salvia miltiorrhiza, radix rehmanniae, coptis chinensis, radix paeoniae rubra, liquorice, fingered citron, calcined dragon bone, calcined oyster shell and rose. The invention aims at the basic pathogenesis of rapid atrial fibrillation dialectically belonging to insufficiency of heart yin, deficiency of essence and blood, unsmooth emotion, blood vessel stasis, stasis depression and fever which are caused by tachycardia and irregular pulse and rhythm. The clinical research proves that the traditional Chinese medicine compound composition can obviously reduce the recurrence frequency and recurrence rate of patients suffering from paroxysmal rapid atrial fibrillation and improve the symptoms of palpitation, chest distress, palpitation and the like of rapid atrial fibrillation, and has the advantages of good clinical curative effect and wide application prospect. The defects of western medicines can be well overcome.
Owner:WENZHOU FUYANTANG NAT MEDICAL CENT CO LTD

Traditional Chinese medicine composition for treating polycystic ovarian syndrome as well as preparation method and application thereof

The invention discloses a traditional Chinese medicine composition for treating polycystic ovarian syndrome and a preparation method thereof. The traditional Chinese medicine composition is prepared from 10-60 parts of rhizoma polygonati, 10-60 parts of radix scrophulariae, 10-60 parts of radix ophiopogonis, 10-60 parts of poria cocos, 10-60 parts of prepared rhizoma atractylodis, 6-36 parts of cortex magnoliae officinalis, 10-60 parts of fried radix paeoniae rubra, 10-60 parts of radix salviae miltiorrhizae, 15-90 parts of caulis spatholobi, 10-60 parts of prepared rhizoma cyperi, 10-60 parts of amethyst, 10-60 parts of spina gleditsiae, 10-60 parts of cassia twig and 20-120 parts of calcined dens draconis. The traditional Chinese medicine composition is obtained by screening through long-term clinical experience and clinical experiments, and experimental results show that the traditional Chinese medicine composition can obviously and continuously improve traditional Chinese medicine syndrome points of patients with polycystic ovarian syndromes, adjust the menstrual cycle and improve acne and hairy states of the patients; the traditional Chinese medicine composition can be used for treating the polycystic ovarian syndrome, reducing the androgen level, luteinizing hormone, the ratio of luteinizing hormone to follicle-stimulating hormone and the fasting insulin level of a patient and improving the ovarian polycystic state under ultrasound, has a good effect of treating the polycystic ovarian syndrome, and is free of toxic and side effects and safe and reliable in medication.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE +1

Glycocholic acid sustained release preparation and production process thereof

The invention discloses a glycocholic acid sustained release preparation and a production process thereof. The glycocholic acid sustained-release preparation comprises glycocholic acid sustained-release pellets, and the preparation method of the glycocholic acid sustained-release preparation comprises the following steps: firstly, preparing glycocholic acid and auxiliary materials into a drug-containing pellet core according to a formula, then coating the drug-containing pellet core with a sustained-release material to obtain the sustained-release pellets, and finally, filling the sustained-release pellets into capsules to obtain the glycocholic acid sustained-release preparation. The preparation method comprises the following steps: carrying out wet granulation-extrusion rolling to obtain wet pills, drying, and coating with a fluidized bed to obtain the glycocholic acid sustained-release pellets. The quality of the drug-loaded pellet is controlled according to indexes such as roundness, bulk density, yield and the like, the drug release effect of the sustained-release pellet is evaluated according to the dissolution rate, and the release mechanism and the initial stability of the glycocholic acid sustained-release pellet are investigated. The invention has the advantages of favorable sustained-release effect, reduced medication frequency, simple and feasible preparation process, favorable reproducibility and favorable drug stability, is suitable for industrial production, aims at supporting the research and development of the compound sustained-release drug, and has obvious social and economic benefits.
Owner:DALIAN UNIV

Medicinal and edible composition for treating infantile anorexia as well as preparation and application thereof

The invention provides a medicinal and edible composition for treating infantile anorexia as well as a preparation and application thereof. The medicinal and edible composition comprises the following raw materials in parts by weight: 15-25 parts of millet, 6-12 parts of scorched hawthorn fruit, 6-12 parts of fried malt, 3-8 parts of endothelium corneum gigeriae galli, 6-12 parts of Chinese yam, 6-12 parts of poria cocos and 6-12 parts of pericarpium citri reticulatae. According to the present invention, the medicinal and edible Qinzhou yellow millet, the scorched hawthorn fruit, the fried malt, the endothelium corneum gigeriae galli, the Chinese yam, the poria cocos and the dried orange peel are adopted as the infantile anorexia treatment prescription, the Qinzhou yellow millet is adopted as the monarch drug, the scorched hawthorn fruit, the fried malt, the endothelium corneum gigeriae galli and the dried orange peel are adopted as the ministerial drugs, and the Chinese yam and the poria cocos are adopted as the conductant drugs, such that the problems of spleen-stomach weakness, dyspepsia, inappetence and the like of the child patient The traditional Chinese medicine composition can promote intestinal tract movement and prevent and improve constipation and other conditions, the total effective rate of the traditional Chinese medicine composition for clinical treatment of child anorexia reaches 100%, the symptoms of child patients are effectively improved, meanwhile, the child patients do not have adverse reactions, and medication is safe; after treatment, the food intake and appetite are normal, relapse is avoided, the relapse rate is low, and the effect is obvious.
Owner:长治医学院附属和济医院

A HPLC detection method for Dashanzhao pills, fingerprint spectrum of Dashanzhao pills and application thereof

The present invention relates to the field of drug analysis technology, and specifically to a Da Shanzhao Pill HPLC detection method, Da Shanzhao Pill fingerprint and application; the detection method includes Da Shanzhao Pill fingerprint and main index component quantitative method. A systematic investigation was conducted on different extraction methods, extraction time, extraction solvent, and extraction volume of samples to screen out the optimal extraction conditions; and the measurement data was systematically analyzed using chemometric tools. The results of the method are reliable and highly accurate, and can reflect the overall quality of commercially available Da Shanzhao Pills; the method can effectively monitor the quality status of Da Shanzhao Pills, and provide a scientific evaluation strategy for the control of the quality consistency and effectiveness of the preparation.
Owner:LANZHOU FOOD & DRUG INSPECTION & TESTING INST

Traditional Chinese medicine compound composition for treating functional dyspepsia and preparation method and application thereof

PendingCN119424578AHigh emptying rateAdjust peristaltic functionDigestive systemBird material medical ingredientsMedicinal herbsSmoked Plum
The invention discloses a traditional Chinese medicine compound composition for treating functional dyspepsia and a preparation method and application thereof. The traditional Chinese medicine compound composition is prepared from 5-20 parts of gordon euryale seeds, 6-12 parts of Chinese yams, 10-30 parts of astragalus membranaceus, 10-30 parts of roasted rhizoma atractylodis macrocephalae, 10-20 parts of smoked plums, 3-15 parts of pericarpium citri reticulatae viride, 10-40 parts of malt, 6-12 parts of roasted endothelium corneum gigeriae galli, 10-20 parts of honey-fried licorice roots and the like. The traditional Chinese medicine composition is prepared according to the theory of treatment based on syndrome differentiation, has the functions of strengthening the spleen and stomach, promotes digestion and absorption, and has an exact treatment effect on related symptoms caused by dyspepsia. Most medicinal materials are medicinal and edible, have small toxic and side effects and are safe and reliable to take.
Owner:JIANGSU HEALTH VOCATIONAL COLLEGE

A compound preparation for treating vascular dementia and a preparation method thereof

This invention discloses a compound preparation for treating vascular dementia and its preparation method. The active pharmaceutical ingredient consists of protopanaxadiol and gallic acid in a 1:1 mass ratio, and the dosage form is liposomes. The preparation method includes extraction, mixing, liposome preparation, and optional freeze-drying steps: protopanaxadiol and gallic acid are extracted and purified from ginseng rhizome and Terminalia chebula fruit, respectively. After mixing, they are combined with phospholipids and cholesterol to prepare a lipid membrane. The membrane is then homogenized by hydration, low-temperature ultrasound, and high-pressure microfluidic jet to obtain a homogeneous liposome suspension, which can be further freeze-dried into a freeze-dried powder. The 1:1 composition of protopanaxadiol and gallic acid targets multiple points on the pathological mechanism of vascular dementia, showing significant therapeutic effects and broad application prospects. This preparation uses a liposome dosage form to improve the bioavailability of the active ingredient, the preparation process parameters are controllable, the active ingredient has high purity, the liposomes have uniform particle size, high encapsulation efficiency, and good stability.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Fingerprint Spectrum Detection Method of Wushen Decoction

The present invention discloses a method for determining the fingerprint of Wushen Decoction. The method comprises: step 1: preparation of a test solution of Wushen Decoction; step 2: preparation of a mixed standard; step 3: respectively accurately aspirating the test solution and the mixed reference solution and injecting them into a high performance liquid chromatograph, and recording the chromatogram; step 4: exporting the data file of the fingerprint of Wushen Decoction obtained in step 3 from the instrument, and importing it into a similarity evaluation system for Chinese medicine chromatographic fingerprints, selecting the chromatographic peaks existing in the chromatograms of different batches of Wushen Decoction as common peaks; generating a control fingerprint of Wushen Decoction by using an average value calculation method; and calculating the relative retention time and relative peak area of ​​each common peak. The fingerprint detection method of Wushen Decoction provided by the present invention has good stability, high precision, and good reproducibility, and can comprehensively and objectively characterize the quality of Wushen Decoction.
Owner:JIANGSU OCEAN UNIV

Traditional Chinese medicine composition for treating diabetes, application of traditional Chinese medicine composition, traditional Chinese medicine preparation and preparation method of traditional Chinese medicine preparation

The invention belongs to the technical field of traditional Chinese medicine preparations, and relates to a traditional Chinese medicine composition for treating diabetes and application thereof, a traditional Chinese medicine preparation and a preparation method. The medicine is prepared from the following raw materials in parts by weight: 10-20 parts of astragalus membranaceus, 10-20 parts of radix polygonati officinalis, 5-15 parts of folium mori, 5-15 parts of gynostemma pentaphylla, 5-15 parts of fried medicated leaven, 3-9 parts of coptis chinensis, 1-5 parts of pseudo-ginseng and 0.5-1.5 parts of cinnamon. The traditional Chinese medicine composition is good in monarch, minister, assistant and guide, and has the effect of improving physical and chemical indexes of diabetics and the like through mutual compatibility. Clinical observation finds that the composition disclosed by the invention can well improve symptoms and signs of patients, is safe in medication, stable and reliable in curative effect and suitable for further popularization and application.
Owner:FUXING HOSPITAL OF CAPITAL MEDICAL UNIV

Depression-resolving and nerve-calming formula for treating insomnia and relieving anxiety and preparation method thereof

The invention belongs to the technical field of traditional Chinese medicine compounds, and provides a depression-resolving and nerve-calming formula for treating insomnia and relieving anxiety and a preparation method thereof, the depression-resolving and nerve-calming formula comprises the following raw materials: 10-30 parts of radix curcumae, 8-24 parts of radix asparagi, 5-15 parts of flos albiziae, 2-6 parts of cortex cinnamomi, 1-3 parts of semen ziziphi spinosae, 1-3 parts of magnetite and 1-3 parts of amber; the depression-resolving and nerve-soothing compound prescription can effectively improve the physical conditions such as eating, hair color and weight of rats with insomnia; the sleep latency period of rats with insomnia is shortened, the sleep duration is prolonged, and the in-vivo 5-HT level is adjusted, so that an exact treatment effect on insomnia is achieved; for a depression rat model, the total activity distance of depression rats can be effectively increased, and the autonomous swimming time and the tail suspension struggling time are prolonged.
Owner:WENZHOU MEDICAL UNIV

Application of Stellera chamaejasme extract in preparing Mongolian medicine for treating prostatitis, mastitis and mumps

The present invention relates to the field of pharmaceutical technology, and in particular to the use of a Stellera chamaejasme extract in the preparation of a Mongolian medicine for treating prostatitis, mastitis and mumps. The Stellera chamaejasme extract of the present invention is applied externally (to the affected part or rectum) to effectively resist inflammation, reduce swelling and relieve pain; it has a unique therapeutic effect on acute and chronic prostatitis, prostatic hyperplasia, acute mumps and mastitis, and has the advantages of good efficacy and short treatment time. The treatment course for acute prostatitis is only 5 days, and 1 to 3 courses of treatment can cure it; mumps can be cured by only 1 to 2 times of medication, and the cure rate is as high as more than 96%; the efficacy is also reliable for acute mastitis during lactation.
Owner:那生桑

Traditional Chinese medicine composition suitable for type II diabetes as well as preparation method and application of traditional Chinese medicine composition

PendingCN121987730AExact curative effectExact medicationMetabolism disorderEndocrine system disorderCorn silkOphiopogon japonicus
The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition suitable for type II diabetes and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 30 to 45 parts of radix astragali seu hedysari, 20 to 30 parts of herba dendrobii, 30 to 45 parts of rhizoma polygonati, 20 to 30 parts of radix ophiopogonis and 20 to 30 parts of corn stigma. According to the traditional Chinese medicine composition, through the synergistic effect of core components such as astragalus membranaceus for tonifying qi, lifting yang, promoting salivation and nourishing blood, dendrobium nobile for tonifying stomach and promoting salivation, polygonatum kingianum for tonifying qi, nourishing yin, moistening lung and tonifying kidney, radix ophiopogonis for nourishing yin and promoting salivation and the like, glucose metabolism balance is effectively adjusted, insulin resistance is improved, and therefore the effect of reducing blood glucose and / or lipid is achieved.
Owner:GUANGMING HOSPITAL OF TRADITIONAL CHINESE MEDICINE PUDONG NEW AREA SHANGHAI

Safflower tendon-relaxing and collateral-activating black plaster for treating traumatic injury and preparation method thereof

The invention discloses a safflower tendon-relaxing and collateral-activating black plaster for treating traumatic injuries and a preparation method of the safflower tendon-relaxing and collateral-activating black plaster. The black plaster is prepared from safflower carthamus, ligusticum wallichii, radix aucklandiae, angelica sinensis, radix paeoniae rubra, cinnamon, garden balsam stem, gentiana macrophylla, fructus cnidii, rhizoma atractylodis, cortex acanthopanacis, geranium wilfordii, rhizoma dioscoreae hypoglaucae, rhizoma acori graminei, ground beetle, calcined native copper, vinegar frankincense, resina draconis, borneol, dendrobe, radix achyranthis bidentatae, peanut oil, red lead, azone and beewax. The black plaster is directly and externally applied to an affected part, is beneficial to exerting the medicine effect, and has the characteristics of low cost, convenience in carrying, suitability for large-scale production and application and the like.
Owner:GUANGZHOU ZHONGXING SPORTS INJURY SPECIALIST HOSPITAL CO LTD

Application of curcumenol in preparation of medicine for treating triple negative breast cancer and pulmonary metastasis

The invention relates to the technical field of medicines, in particular to application of curcumenol in preparation of a medicine for treating triple negative breast cancer and pulmonary metastasis. The invention provides an effective selectable scheme for the treatment of the triple negative breast cancer. The curcumenol has an obvious inhibition effect on the proliferation ability, migration ability, invasion ability and colony ability of triple-negative breast cancer cells from different sources, has an obvious anti-tumor growth effect on triple-negative breast cancer mice, and can obviously inhibit the lung metastasis progress of triple-negative breast cancer model mice; and obvious toxic and side effects are not caused while tumors are effectively inhibited. Natural products are adopted, and medication is safe.
Owner:LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE

Traditional Chinese medicine composition for treating hyperlipemia

The invention relates to a traditional Chinese medicine composition for treating hyperlipemia, which can effectively solve the medication problem of hyperlipemia. The traditional Chinese medicine composition is prepared from, by weight, 15-25 g of lotus leaves, 13-23 g of rhizoma alismatis, 6-12 g of flos carthami, 6-12 g of peach kernels, 4-8 g of poria cocos, 4-8 g of rhizoma atractylodis macrocephalae, 4-8 g of agastache rugosus, 4-8 g of herba eupatorii, 8-16 g of pinellia ternate, 8-16 g of gynostemma pentaphyllum, 8-16 g of semen cassiae, 6-12 g of ligusticum wallichii and 4-8 g of scutellaria baicalensis. The traditional Chinese medicine composition for treating hyperlipemia has the advantages that the effect of treating hyperlipemia with intermingled phlegm and blood stasis is obvious, the hyperlipemia can be effectively improved, the medication is safe, no obvious adverse reaction exists, and the traditional Chinese medicine composition is an innovation of hyperlipemia treatment medicines.
Owner:THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM

Freeze-drying process and application thereof

The invention relates to the technical field of medicine production, and discloses a freeze-drying process and application thereof. The freeze-drying process comprises the step of enabling a sample to sequentially pass through a pre-freezing stage, a primary drying stage and a secondary drying stage to obtain a freeze-dried product, in the pre-freezing stage, a cooling-heating-cooling mode is adopted, and the temperature change range is-50 DEG C to-10 DEG C; the primary drying stage comprises three times of slope heating, and the temperature change range is-50 DEG C to-2 DEG C; the secondary drying stage comprises three times of slope heating, and the temperature change range is-2 DEG C to 30 DEG C. According to the freeze-drying process provided by the invention, by adopting a cooling-heating-cooling pre-freezing mode, the crystallization rate of the sample is effectively improved, the water solubility of the freeze-dried sample is good, the sublimation drying time is effectively shortened, and the freeze-drying efficiency is accelerated; and in the primary drying stage and the secondary drying stage, the heating temperature parameter and the vacuum degree are controlled, so that the freeze-dried sample shows a relatively good appearance and has a proper water content.
Owner:GUANGDONG WELLITE BIOMEDICAL TECH CO LTD

Traditional Chinese medicine composition for treating hypertension or hypertension combined with hyperlipidemia and preparation method thereof

The present invention belongs to the technical field of Chinese medicine preparation, and specifically relates to a Chinese medicine composition for treating hypertension or hypertension combined with hyperlipidemia and a preparation method thereof. The Chinese medicine composition for treating hypertension or hypertension combined with hyperlipidemia of the present invention is composed of the following raw materials in parts by weight: 8-20 parts of stinking knotweed, 8-20 parts of polyphemus, 1-5 parts of astragalus, 1-5 parts of mistletoe, 3-6 parts of siler, 1-5 parts of glossy privet, 1-5 parts of oriental rhizome, 1-2 parts of eucommia bark, 1-2 parts of ligusticum, 1-2 parts of ligusticum, 1-2 parts of chuanxiong, and 1-2 parts of earthworm. The Chinese medicine composition of the present invention has good antihypertensive and lipid-lowering effects, can effectively treat hypertension, has little side effects, and is particularly suitable for hypertension combined with hyperlipidemia.
Owner:REYOUNG PHARMA CO LTD

A traditional Chinese medicine composition for treating depression

ActiveCN118593560BEffective against stress-induced depressionsimple recipeNervous disorderPlant ingredientsTraditional medicineChinese herbology
The present application relates to a kind of traditional Chinese medicine composition for treating depression, relate to the technical field of traditional Chinese medicine, by weight parts, the traditional Chinese medicine composition for treating depression includes the following raw materials: 50~80 parts of hair and 10~25 parts of Chinese hackberry.The traditional Chinese medicine composition provided by the present application is mainly hair and supplemented with appropriate Chinese hackberry, both are used in combination, can treat depression together, and the effect of anti-stress depression is remarkable, formula is simple, drug is safer, provides a new means for the treatment of depression patients.
Owner:新疆医科大学第四附属医院

Vilanterol triphenylacetate inhalation solution and preparation method thereof

The present invention provides a solution of vilanterol triphenylacetate for inhalation, a preparation method and an application thereof, wherein the inhalation solution comprises an active substance, a solvent and an excipient. The single-dose specification of the inhalation solution is 1 ml, and the single-dose specification comprises 15 to 50 μg / mL of vilanterol triphenylacetate and / or its hydrate as an active substance; the solvent is water for sterile injection, and the excipients comprise an osmotic pressure regulator and a pH regulator, the osmotic pressure regulator has a concentration of 5 to 9 mg / ml, and the pH regulator is added to make the pH value of the inhalation solution preparation be 5.0 to 7.0. The solution of the present invention is packaged in a single dose, does not contain a preservative, is safe and convenient to use, and is used in combination with a liquid nebulizer to provide a safe, effective and stable pharmaceutical dosage form and drug delivery system for inhalation of vilanterol triphenylacetate.
Owner:BEIJING INCREASE INNOVATIVE DRUG RESEARCH CO LTD

A Qi-boosting and Blood-activating Granule for Heart Pain and its Preparation Method

This invention relates to the field of traditional Chinese medicine preparation technology, specifically to a Qi-invigorating and blood-activating granule for heart pain and its preparation method, comprising the following raw materials in parts by weight: 25-35 parts of raw Astragalus membranaceus, 10-20 parts of Angelica sinensis, 5-15 parts of ginseng, 4-8 parts of Panax notoginseng, 10-20 parts of Ligusticum chuanxiong, 8-12 parts of earthworm, and 2-4 parts of leech. This invention precisely targets the core pathogenesis of Qi deficiency and blood stasis syndrome, which is "Qi deficiency as the root and blood stasis as the manifestation," selecting raw Astragalus membranaceus and ginseng as the core Qi-invigorating components, and Panax notoginseng, leech, Ligusticum chuanxiong, Angelica sinensis, and earthworm as the core blood-activating components. The formulation follows the traditional Chinese medicine principle of "invigorating Qi to promote blood circulation without harming the body's vital energy." The dosage of each raw material has been optimized through systematic experiments to form a specific range of parts by weight, solving the technical problems of poor targeting and insufficient synergy in existing formulations.
Owner:BEIJING FANGSHAN DISTRICT HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Externally applied traditional Chinese medicine formula for treating innominate pyogenic infections and preparation method of externally applied traditional Chinese medicine formula

The invention provides an externally-applied traditional Chinese medicine formula for treating innominate pyogenic infections and a preparation method of the externally-applied traditional Chinese medicine formula, and relates to the technical field of externally-applied traditional Chinese medicines, and the externally-applied traditional Chinese medicine formula comprises rhizoma atractylodis macrocephalae, Mitsubishi, spina gleditsiae, Chinese honeylocust fruit, dried seven roots, croton seeds, centipedes, raw turtle shells, minium, raw pangolin scales, ground beetles, musk, raw ginger, fistular onion stalks and sesame oil. The traditional Chinese medicine is externally applied to treat innominate pyogenic infections, the traditional Chinese medicine is directly attached to the outer surface of the skin to achieve the treatment purpose, oral treatment is not needed, the medicine effect of the formula is not absorbed through the digestive tract, and the influence of various digestive systems and the metabolic function of the liver can be avoided; the traditional Chinese medicine composition is safe and reliable in medication, free of toxic and side effects, free of stimulation to viscera, capable of accelerating metabolism and enhancing the immunity of the body, good in treatment effect and high in cure rate, and provides a safer and more comfortable treatment environment for patients, and external application of the traditional Chinese medicine composition is achieved.
Owner:王成军

Dexmedetomidine hydrochloride oral soluble film as well as preparation method and application thereof

The invention relates to a dexmedetomidine hydrochloride oral soluble film, which is prepared from the following components in percentage by weight: 0.1 to 10 percent of dexmedetomidine hydrochloride and 90 to 99.9 percent of film forming material, the film forming material is selected from any one or a combination of copovidone, a polyvinyl caprolactam polyvinyl acetate polyethylene glycol grafted copolymer, hydroxypropyl methyl cellulose, hydroxy propyl cellulose, hydroxyethyl cellulose, polyvinyl alcohol, polyoxyethylene, povidone and poloxamer. The dexmedetomidine hydrochloride oral soluble film has the advantages of fast disintegration time in the oral cavity, good mechanical extrusion performance, good film forming performance and high content uniformity, meets the requirements of cutting, packaging, transportation, clinical use and the like, significantly improves the dissolution rate, dissolution rate, stability and bioavailability, does not need to be taken with water, significantly improves the compliance of child patients, and has a good application prospect. The medication safety and effectiveness are ensured.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Melsartan potassium photodegradation impurity and preparation method thereof

The invention belongs to the field of biological medicine, and particularly relates to a Milsartan potassium photodegradation impurity and a preparation method thereof. The method comprises the following steps: carrying out illumination destruction on Milsartan potassium powder under the condition of contacting with air, enriching with an organic solvent, carrying out column chromatography separation and recrystallization purification to obtain the novel Milsartan potassium photodegradation impurity, and the highest purity of the obtained impurity is 99.6%. The photodegradation impurity disclosed by the invention is actually detected in related substance inspection of a photostability test of a Milsartan potassium raw material medicine and a Milsartan potassium preparation, the detection values are respectively 0.23% and 0.25%, and the photodegradation impurity is one of main degradation impurities and has research necessity; the structure of the impurity compound is represented, and the impurity compound can be used as an impurity reference substance and is used for analysis, detection, quality control and the like of Milsartan potassium bulk drugs and preparations.
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV

Application of Xinsunning preparation in preparation of medicine for preventing or treating vagus nerve atrial fibrillation

The invention belongs to the technical field of medicine application, and relates to an application of a Xinsunning preparation in preparing a medicine for preventing or treating vagus nerve atrial fibrillation, the Xinsunning preparation reduces the occurrence rate of vagus nerve atrial fibrillation, shortens the time of vagus nerve atrial fibrillation, reduces the P-wave time history of vagus nerve atrial fibrillation, and improves the treatment effect of the vagus nerve atrial fibrillation. The sympathetic nerve tension and the sympathetic nerve activity are obviously reduced, and the vagus nerve tension and the vagus nerve activity are obviously improved, so that the vagus nerve atrial fibrillation is prevented or treated, and the dosage of the Xinxin preparation for preventing or treating the vagus nerve atrial fibrillation is 0.041 g / kg.d to 0.165 g / kg.d. The invention provides a new way for the application of the Xinsunning preparation in preparation of medicines for preventing and treating vagus nerve atrial fibrillation.
Owner:SHAANXI MOMENTUM QIXUEHE PHARMACEUTICAL CO LTD

Desmopressin oral solution and preparation method thereof

The invention discloses a desmopressin oral solution and a preparation method thereof. The desmopressin oral solution preparation comprises the following raw materials: desmopressin acetate, a bacteriostatic agent, a pH regulator and purified water. The preparation method of the desmopressin oral solution comprises the following steps: adding purified water accounting for 65-80% of the total mass, sequentially adding a bacteriostatic agent and desmopressin acetate, and mixing and stirring until the bacteriostatic agent and desmopressin acetate are completely dissolved; diluted hydrochloric acid is added, and the pH value of the solution is adjusted to 4.0-5.0; adding purified water to the total volume; and filtering and filling to obtain the desmopressin oral solution. The desmopressin oral solution is simple in preparation method, stable in product quality and suitable for commercial production, meanwhile, the dosage of the bacteriostatic agent is optimized, the product safety degree is higher, and the dosage form of the oral solution is more suitable for children and patients with dysphagia to take medicine.
Owner:JINZHOU AHON PHARM CO LTD

Small molecule drug-oligonucleotide conjugate and its application

ActiveCN115282283BImprove solubility propertiesImprove tissue distribution in the bodyOrganic active ingredientsSenses disorderDiseaseNucleotide
The present invention provides a small molecule drug-oligonucleotide conjugate and its application, belonging to the field of biomedical technology. The present invention aims at the problems of poor water solubility and difficulty in drug delivery of existing small molecule immunomodulatory drugs, and adopts a method of coupling with oligonucleotide drugs. On the one hand, the excellent hydrophilicity of oligonucleotides can improve the solubility properties of small molecule drugs, improve their tissue distribution in the body, and promote delivery and absorption. At the same time, hydrophobic small molecule drugs can also promote the entry of oligonucleotides into cells, thereby enhancing their ability to regulate target genes. Secondly, the present invention achieves synergistic regulation of different targets of inflammatory response by co-delivery of small molecule drugs and functional oligonucleotide molecules, thereby achieving better disease treatment effects and achieving safe and efficient drug use.
Owner:SHANGHAI JIAOTONG UNIV +1

Traditional Chinese medicine composition for treating pelvic floor muscle spasm syndrome and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating pelvic floor muscle spasm syndrome, and belongs to the field of traditional Chinese medicines. The invention discloses a traditional Chinese medicine composition for treating pelvic floor muscle spasm syndrome. The traditional Chinese medicine composition is prepared from, by weight, 9-20 parts of cassia twigs, 9-20 parts of radix paeoniae alba, 20-40 parts of radix bupleuri, 9-20 parts of radix curcumae, 10-30 parts of angelica sinensis, 10-30 parts of ligusticum wallichii, 30-60 parts of oysters, 9-20 parts of fossil fragments, 5-15 parts of processed radix aconiti carmichaeli, 15-30 parts of radix polygonati officinalis, 5-10 parts of folium artemisiae argyi, 5-10 parts of almonds, 10-30 parts of peach kernels, 5-15 parts of honey-fried licorice roots, 9-20 parts of fresh ginger and 5-15 parts of Chinese dates.
Owner:张焱

Oral liquid for alleviating premature ovarian failure and preventing cervical cancer and preparation method thereof

The oral liquid is prepared from the following traditional Chinese medicine raw materials in parts by weight: 4-7 parts of colla corii asini, 5-9 parts of radix polygonati officinalis, 3-7 parts of endothelium corneum gigeriae galli, 12-20 parts of cuttlefish, 7-13 parts of rhizoma polygonati, 6-11 parts of ginseng, 5-11 parts of poria cocos, 1-4 parts of angelica sinensis, 3-10 parts of radix ophiopogonis, 2-7 parts of chrysanthemum, 1-4 parts of radix puerariae, 2-5 parts of loofah sponge, 2-5 parts of clove, 3-6 parts of rice wine and 0-2 parts of white granulated sugar. Various traditional Chinese medicines contain various beneficial components, follow the medication principle of a traditional Chinese medicine prescription, are reasonable in formula, safe in medication, good in curative effect and convenient to use, and have obvious effects of regulating qi and blood of women, relieving premature ovarian failure, improving sleep, delaying climacteric and preventing cervical cancer.
Owner:GUANGXI MIAOCOTANG HEALTH IND CO LTD

Composition for treating blood sugar rise caused by SARS-CoV-2 infection as well as preparation method, application and medicine

ActiveCN119112870Aaccurate medicationmedication safetyMetabolism disorderHydroxy compound active ingredientsMagnololQuercitrin
The invention provides a composition for treating blood glucose rise caused by SARS-CoV-2 infection, a preparation method, application and a medicine, and relates to the field of pharmaceutical compositions. The composition is prepared from the following components in parts by weight: 10 to 40 parts of rheum emodin, 15 to 60 parts of magnolol, 2.5 to 10 parts of quercetin, 10 to 40 parts of acanthochalcone and 10 to 20 parts of formononetin. The composition has the effect of treating blood glucose rise caused by SARS-CoV-2 infection, and OGTT and ITT experiment results show that the composition can significantly improve fasting blood glucose and glucose tolerance of mice, effectively reduce adverse effects of SARS-CoV-2 infection on an endocrine system and improve the living quality of patients.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Carbamazepine non-aqueous transdermal absorption patch and preparation method thereof

The invention is suitable for the technical field of drug-loaded polymer medical preparations, and provides a carbamazepine non-aqueous transdermal absorption patch and a preparation method thereof, the carbamazepine non-aqueous transdermal absorption patch comprises the following components by mass: 0.5%-10% of carbamazepine, 10%-50% of a matrix, 0.1%-1.5% of an antioxidant, 0.5%-10% of a cosolvent, 0.1%-10% of a penetration enhancer, 5%-70% of a plasticizer, and 10%-70% of a tackifier; preferably, the carbamazepine tablet comprises the following components in percentage by mass: 1%-5% of carbamazepine, 10%-30% of the matrix, 0.1%-1% of the antioxidant, 1%-5% of the cosolvent, 0.1%-5% of the penetration enhancer, 10%-50% of the plasticizer and 10%-50% of the tackifier. The prepared patch is convenient and safe to use, the compliance of a patient is greatly improved, the drug release rate is high, the oral absorption rate of carbamazepine is increased, the drug effect is stable, and clinical requirements are met.
Owner:BEIJING LIANSHENG TRANSDERMAL MEDICAL TECHNOLOGY CO LTD